Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 HCV and HIV-1 Co-infection

Clinical trial NCT02480387 · COMPLETED

Trial details

NCT number: NCT02480387
Sponsor: Peter J. Ruane, M.D., Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment of Hepatitis C

Start date: 2015-05-01
Primary completion: 2015-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.